Historical return extremes for Relmada Therapeutics (RLMD) from 2014 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +3,022% | $0.25 | $7.86 | $31,215.25 | ||
| Max drawdownMore info about Max drawdown | -98.31% | $14.88 | $0.25 | $16.92 | ||
| Return since IPOMore info about Return since IPO | -44.58% | $12 | $6.65 | $554.17 |
- Max profitMore info about Max profit+3,022%$31,215.25
- Max drawdownMore info about Max drawdown-98.31%$16.92
- Return since IPOMore info about Return since IPO-44.58%$554.17
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Relmada Therapeutics (RLMD). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Relmada Therapeutics (RLMD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement